SCHEMBL7512230

SCHEMBL7512230

OCCOC1(c2ccccc2)CCNCC1

nearest known ligand 0.47

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 5/20 0.47
TACR1 P25103 6/20 0.42
HTR2A P28223 1/20 0.41
OPRD1 P41143 3/20 0.40
OPRK1 P41145 3/20 0.40
OPRL1 P41146 3/20 0.40
DRD3 P35462 1/20 0.40
AKT2 P31751 1/20 0.36
ALDH1A1 P00352 1/20 0.36
RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6543335 0.98 OPRM1 (0.46) OPRM1TACR1HTR2AOPRD1OPRK1
SCHEMBL3018551 0.83 OPRM1 (0.57) OPRM1TACR1HTR2AOPRD1OPRK1
Hydrochloric Acid SCHEMBL8367126 0.81 DRD3 (0.45) OPRM1TACR1HTR2AOPRD1OPRK1
SCHEMBL28865491 0.81 OPRM1 (0.48) OPRM1TACR1HTR2AOPRD1OPRK1
SCHEMBL8329089 0.79 OPRM1 (0.55) OPRM1TACR1HTR2AOPRD1OPRK1
Hydrochloric Acid SCHEMBL18424795 0.78 OPRM1 (0.54) OPRM1TACR1HTR2AOPRD1OPRK1
SCHEMBL11536155 0.75 OPRM1 (0.46) OPRM1TACR1HTR2AOPRD1OPRK1
SCHEMBL11535461 0.75 OPRM1 (0.46) OPRM1TACR1HTR2AOPRD1OPRK1
SCHEMBL24944034 0.74 OPRM1 (0.48) OPRM1TACR1HTR2AOPRD1OPRK1
SCHEMBL8827332 0.74 DRD3 (0.62) OPRM1OPRD1OPRK1OPRL1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1241168-A1 Human NK3 receptor-selective antagonist compounds, process for their obtention and pharmaceutical compositons containing them SANOFI-SYNTHELABO (FR) 2002-09-18 EP disclosed
EP-1019373-A1 NOVEL HUMAN NK 3? RECEPTOR-SELECTIVE ANTAGONIST COMPOUNDS, METHOD FOR OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SANOFI-SYNTHELABO (FR) 2000-07-19 EP disclosed
WO-1997010211-A1 NOVEL HUMAN NK3 RECEPTOR-SELECTIVE ANTAGONIST COMPOUNDS, METHOD FOR OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SANOFI (FR) 1997-03-20 WO disclosed